News & Events

Diane Morse Named Associate Director of the Office of Health Equity Research

Friday, March 22, 2024

Diane Morse, MD, has been named associate director of the Office of Health Equity Research (OHER), now part of the Center for Community Health & Prevention at the University of Rochester Medical Center (URMC). Dr. Morse is an internal medicine physician and associate professor of Psychiatry and Internal Medicine at the URMC. An avid researcher with particular interest in the health care needs of individuals in the criminal legal system, domestic violence, and health equity, she also leads the WISH-TC (Wellness Initiative Supporting Health Transitions) clinic at Jordan Health.

Edith Williams Named Director of the Center for Community Health & Prevention

Thursday, January 18, 2024

After a nearly year-long search, URMC CEO Mark Taubman, MD, named Edith Williams, MS, PhD, director of the Center for Community Health & Prevention (CCHP). Williams joined URMC in 2022 as the founding director of the Office of Health Equity Research.

"The CCHP has provided a critical connection between our Medical Center and the communities we serve for nearly 20 years," said Taubman, who is also dean of the School of Medicine and Dentistry. "As a Rochester native with deep experience in health equity research, Dr. Williams is perfectly poised to lead the Center and build on URMC's deep commitment to community health."

Emerging Infections Program Receives $4.185 Million Grant Renewal

Monday, January 8, 2024

UR Medicine’s Center for Community Health & Prevention (CCHP), in collaboration with the New York State Department of Health, has recently secured a significant annual grant of $4,185,700 million through a competitive renewal process from the CDC Emerging Infections Program (EIP). This five-year grant underscores the enduring commitment and success of the NYS EIP, which has received continuous funding for nearly three decades.

The EIP operates as a robust network, currently comprised of 10 state health departments, focused on utilizing public health practices to effectively address emerging infections. In collaboration with academic institutions, laboratories, and other public health entities, the program plays a crucial role in generating population-based communicable disease data. This data, essential for monitoring disease patterns, evaluating vaccine effectiveness, and identifying at-risk populations, is instrumental in shaping public health policies and interventions.